The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheum with a View

Rheum with a View

July 12, 2011 • By Richard S. Panush, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Richard S. Panush, MD

PERRLA

How many times do we write this or see this recorded or presented without really carefully examining the eye or the fundus? How many of us still look at the fundus? Most medical residents don’t even carry or own ophthalmoscopes and have little comfort with the exam of the eye or fundus. This leads me to the new recommendations regarding antimalarials. Recently, my college and medical school roommate, Marty Pearlman, MD, and his wife visited my wife and me. Marty went into ophthalmology and now does retinal surgery in Lansing, Michigan. Marty’s love for what he does is so infectious that two of his four children are also ophthalmologists; in fact, one of them specializes in the retina.

You Might Also Like
  • Rheum With a View
  • Rheum with a View
  • Rheum with a View
Explore This Issue
July 2011
Also By This Author
  • Rheum with a View

During our visit, Marty informed me that the American Academy of Ophthalmology (AAO) developed a new set of recommendations on screening for antimalarials.1 I was unaware of this—and perhaps others are, too. Briefly, these are revisions of 2002 recommendations. This update was prompted by improved screening tools and data, suggesting that risk of drug toxicity increases toward 1% after five to seven years of use or a cumulative dose of 1,000 grams of hydroxychloroquine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Recommendations are that a routine dosage of 400 mg hydroxychloroquine daily is acceptable for all, but for individuals of short stature (rather than dosing by weight), baseline evaluation should be carried out, annual screening should begin after five years unless there are unusual risks, and at least one of the newer tests—multifocal electroretinogram (mfERG), spectral domain optical coherence tomography, or fundus autofluorescence—should be used routinely. Additionally, mfERG may replace the visual field exam, Amsler grid testing is no longer needed, and fundus exams should be documented. (Editor’s Note: For more on the new AAO guidelines, see “Hydroxychloroquine Retinopathy Still Alive and Well” in the May 2011 issue of The Rheumatologist, p. 50, or online at www.the-rheumatologist.org/details/article/1066217/.html.)

Marty has done very well, and I couldn’t be happier for his success. I recall when I moved out of our shared apartment (I was getting married) that Marty and I had to split our stuff, most of which had little value. I lost the final coin flip, so he got the good rug, and I was left with the stethoscopic heart sounds record. So, he still owes me; maybe he can show me how to do some of those retinal tests.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
What is contained in a tear?
What is contained in a tear?

There Will Never Be a Panush’s Syndrome

Nor will there be a Panush’s disease, or even Panush’s sign. My mom (may she rest in peace) would have been disappointed. We all were notified electronically about the recommendations of the ACR, the American Society of Nephrology, and European League Against Rheumatism to begin shifting away from eponyms.2 This was prompted “by evidence that Dr. Friedrich Wegener was a member of the Nazi party before and during World War II,” according to the authors of the article, which was published in Arthritis & Rheumatism, Dr. Wegener may also have been complicit with war crimes.

Pages: 1 2 3 | Single Page

Filed Under: Practice Management, Profiles Tagged With: HYDROXYCHLOROQUINE, patient care, Practice Management, retina, rheumatologist, TreatmentIssue: July 2011

You Might Also Like:
  • Rheum With a View
  • Rheum with a View
  • Rheum with a View
  • Rheum with a View

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)